[1]
Cakir, L. 2025. Polypharmacy in Type 2 Diabetes Mellitus and Related Conditions: A Double-Edged Sword: A Narrative Review. Advances in Clinical Pharmacology and Therapeutics. 2, 2 (Sep. 2025), 39–46. DOI:https://doi.org/10.63623/sr9fb890.